Guided Therapeutics, Inc. is a medical technology company focused on developing medical devices. The Company's focus is the sales and marketing of its LuViva Advanced Cervical Scan. LuViva is a non-invasive cervical cancer detection product, based on the Company's biophotonic technology. The device is designed to identify cervical cancers and precancers painlessly, non-invasively and at the point-of-care by scanning the cervix with light, then analyzing the light reflected or emanating from the cervix. The information presented by the light is used to indicate the likelihood of cervical cancer or precancers. LuViva is also designed to detect the biochemical changes that precede the development of visual lesions. It has approval to sell the product LuViva in Canada, Mexico, Singapore, the European Union and additional countries. It has completed the pivotal trial for LuViva and has filed its premarket approval (PMA) application with the United States Food and Drug Administration (FDA).
|Headquarters||5835 Peachtree Cors E Ste D|
NORCROSS, GA, United States 30092-3413
|Independent Chairman and Director||Michael James|
|President, Chief Executive Officer and Acting Chief Financial Officer||Gene Cartwright|
|Senior Vice President - Engineering||Richard Fowler|
|Independent Director||Ronald Hart|
|Independent Director||John Imhoff|
|Shares Out.||163.7M||Book Value||$-0.05|
|Guided Therapeutics Inc does not pay a dividend.||P/E||--|
|P/Cash Flow (TTM)||--|
*GAAP = prior to non-GAAP analyst adjusted earnings.